CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment

Published:2015-11-25 Issue:5 Volume:37 Page:6073-6084
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Wan Xin,Cheng Ci,Shao Qing,Lin Zhe,Lu Shuai,Chen Yun

Funder

National Natural Science Foundation

National Natural Science Foundation of China (CN)

Jiangsu science and technology innovation Program for graduate Research Funds

Six talent peaks project of Jiangsu Province

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-4442-7.pdf

Reference57 articles.

1. Springer T, Galfre G, Secher DS, Milstein C. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J Immunol. 1978;8:539–51.

2. Sagiv E, Arber N. The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Expert Rev Gastroenterol Hepatol. 2008;2(1):125–33.

3. Tan Y, Zhao M, Xiang B, Chang C, Lu Q. CD24: from a hematopoietic differentiation antigen to a genetic risk factor for multiple autoimmune diseases. Clin Rev Allergy Immunol. 2015. doi: 10.1007/s12016-015-8470-2 .

4. Liu JQ, Carl Jr JW, Joshi PS, RayChaudhury A, Pu XA, Shi FD, et al. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. J Immunol. 2007;178(10):6227–35.

5. Fang X, Zheng P, Tang J, Liu Y. CD24: from A to Z. Cell Mol Immunol. 2010;7(2):100–3.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies;Immunology;2024-08-11

2. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma;Scientific Reports;2024-06-18

3. Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinoma;Egyptian Liver Journal;2024-05-23

4. Targeting CD24 as a novel immunotherapy for solid cancers;Cell Communication and Signaling;2023-11-02

5. Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway;Advanced Science;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3